Abbott Speaks Lingo Wearables For Future Growth, Posts Formula As Current Consumer Sales Driver

Lingo’s target “is to do something that not a lot of well-established health care companies do, which is to create a product that's really targeting a healthy population and a healthy population that wants to stay healthy,” says CEO Robert Ford.

Lingo
Lingo prototype sensor with screen of smartphone app Abbott shared with its January 2022 announcement of the product's development. • Source: Abbott

Falling sales of OTC and other diagnostics, on one hand, and regaining infant formula market share on the other take a back seat in Abbott’s latest results as the firm debuts its Lingo line of consumer bio-wearables in the UK.

CEO Robert Ford said during Abbott’s earnings briefing on 20 July that the firm plans to file for US approval

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Earnings

More from Business